Clinical trial
Prevention of Corticosteroid-induced Glucose Intolerance
NCT00240604 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00240604 |
|---|---|
| Title | Prevention of Corticosteroid-induced Glucose Intolerance |
| Official title | Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glucose Intolerance |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 100 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2013 |
| Completion | Oct 1, 2015 |
| First posted | Oct 18, 2005 |
| Last update posted | Sep 14, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: